HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simvastatin improves disturbed endothelial barrier function.

AbstractBACKGROUND:
Recent clinical trials have established that inhibitors of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (statins) reduce the risk of acute coronary events. These effects of statins cannot be fully explained by their lipid-lowering potential. Improved endothelial function may contribute to the positive effects of statin treatment.
METHODS AND RESULTS:
In the present study, we report that simvastatin reduces endothelial barrier dysfunction, which is associated with the development of atherosclerosis. Treatment of human umbilical vein endothelial cells for 24 hours with 5 micromol/L simvastatin reduced the thrombin-induced endothelial barrier dysfunction in vitro by 55+/-3%, as assessed by the passage of peroxidase through human umbilical vein endothelial cell monolayers. Similar effects were found on the thrombin-induced passage of (125)I-LDL through human aortic endothelial cell monolayers. This reduction in barrier dysfunction by simvastatin was both dose and time dependent and was accompanied by a reduction in the thrombin-induced formation of stress fibers and focal adhesions and membrane association of RhoA. Simvastatin treatment had no effect on intracellular cAMP levels. In Watanabe heritable hyperlipidemic rabbits, treatment for 1 month with 15 mg/kg simvastatin reduced vascular leakage in both the thoracic and abdominal part of the aorta, as evidenced by the Evans blue dye exclusion test. The decreased permeability was not accompanied by a reduction of oil red O-stainable atherosclerotic lesions.
CONCLUSIONS:
These data show that simvastatin, in a relatively high concentration, improves disturbed endothelial barrier function both in vitro and in vivo. The data also support the beneficial effects of simvastatin in acute coronary events by mechanisms other than its lipid-lowering effect.
AuthorsG P van Nieuw Amerongen, M A Vermeer, P Nègre-Aminou, J Lankelma, J J Emeis, V W van Hinsbergh
JournalCirculation (Circulation) Vol. 102 Issue 23 Pg. 2803-9 (Dec 05 2000) ISSN: 1524-4539 [Electronic] United States
PMID11104736 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cholesterol, LDL
  • Cholesterol
  • Simvastatin
Topics
  • Animals
  • Aorta (drug effects, metabolism, physiopathology)
  • Arteriosclerosis (physiopathology, prevention & control)
  • Capillary Permeability (drug effects, physiology)
  • Cell Membrane Permeability (drug effects, physiology)
  • Cells, Cultured
  • Cholesterol (blood, metabolism)
  • Cholesterol, LDL (blood, metabolism)
  • Disease Models, Animal
  • Endothelium, Vascular (drug effects, metabolism, physiopathology)
  • Humans
  • Hypercholesterolemia (physiopathology, prevention & control)
  • Rabbits
  • Simvastatin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: